Compagnie Lombard Odier SCmA’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $185M | Buy |
|
|||||
2025
Q1 | $182M | Buy |
|
|||||
2024
Q4 | $98.5M | Buy |
|
|||||
2024
Q3 | $63.2M | Buy |
|
|||||
2024
Q2 | $59.6M | Buy |
|
|||||
2024
Q1 | $43.4M | Buy |
|
|||||
2023
Q4 | $24.1M | Buy |
|
|||||
2023
Q3 | $9.33M | Buy |
|
|||||
2023
Q2 | $2.93M | Buy |
|
|||||
2023
Q1 | $1.13M | Buy |
|
|||||
2022
Q4 | $612K | Buy |
|
|||||
2022
Q3 | $284K | Sell |
|
|||||
2022
Q2 | $446K | Buy |
|
|||||
2022
Q1 | $291K | Sell |
|
|||||
2021
Q4 | $333K | Buy |
|
|||||
2021
Q3 | $209K | Hold |
|
|||||
2021
Q2 | $207K | Hold |
|
|||||
2021
Q1 | $169K | Sell |
|
|||||
2020
Q4 | $296K | Buy |
|
|||||
2020
Q3 | – | Hold |
|
|||||
2020
Q2 | – | Hold |
|
|||||
2019
Q4 | – | Sell |
|
|||||
2019
Q3 | $50K | Buy |
|
|||||
2019
Q2 | – | Sell |
|
|||||
2019
Q1 | $104K | Hold |
|
|||||
2018
Q4 | $93K | Hold |
|
|||||
2018
Q3 | $86K | Buy |
|
|||||
2018
Q2 | $35K | Hold |
|
|||||
2018
Q1 | $32K | Sell |
|
|||||
2017
Q4 | $70K | Sell |
|
|||||
2017
Q3 | $154K | Hold |
|
|||||
2017
Q2 | $149K | Buy |
|
|||||
2017
Q1 | $84K | Sell |
|
|||||
2016
Q4 | $935K | Buy |
|
|||||
2016
Q3 | $319K | Buy |
|
|||||
2016
Q2 | $284K | Sell |
|
|||||
2016
Q1 | $780K | Buy |
|
|||||
2015
Q4 | $875K | Buy |
|
|||||
2015
Q3 | $857K | Buy |
|
|||||
2015
Q2 | $848K | Sell |
|
|||||
2015
Q1 | $794K | Buy |
|
|||||
2014
Q4 | $207K | Sell |
|
|||||
2014
Q3 | $944K | Sell |
|
|||||
2014
Q2 | $908K | Sell |
|
|||||
2014
Q1 | $1.16M | Buy |
|
|||||
2013
Q4 | $842K | Buy |
|